Menu
Recruiting NCT05962879

Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness

No phase Interventional Anxiety Disorders Psychotic Disorders Depressive Disorder Psychosocial Functioning

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Resilience Training for Teens.
Who it may be relevant to
Registry conditions: Anxiety Disorders, Psychotic Disorders, Depressive Disorder, Psychosocial Functioning. Basic parameters: 14 years — 19 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This research study aims to develop a brief group-based treatment called Resilience Training for Teens, then to test how well it protects high school students with mild symptoms of depression, anxiety, or having unusual feelings from developing mental illnesses.

Interventions

  • Behavioral Resilience Training for Teens
    A brief 6-session group-based behavioral intervention for high school aged teenagers at risk of a mental illness.

Primary outcome measures

  • Structured Interview of Psychosis-risk Syndromes (SIPS) [Time frame: 1 year]
Secondary outcome measures (2)
  • Child Behavior Checklist (CBCL) [Time frame: 1 year]
  • Global Functioning Social and Role Scales [Time frame: 1 year]

Eligibility criteria

Inclusion criteria

  • Currently enrolled in 9th through 12th grade and between the ages of 14 and 19
  • Endorsed at least one psychotic experience
  • Provided contact information
  • Have a parent or legal guardian who is able and willing to provide written informed consent (if under the age of 18)
  • Have a parent or legal guardian who is able and willing to participate in a parent session
  • Competent and willing to provide written informed assent (if under the age of 18) or consent (if age 18 or older)
  • Able to communicate in English

Exclusion criteria

  • Currently prescribed psychotropic medication (not including medications for attention deficit/hyperactivity disorder), regardless of adherence
  • Currently obtaining psychotherapeutic intervention

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Prevention

Study locations

United States · 1 center
  • Massachusetts General Hospital — Boston

Identifiers

NCT: NCT05962879 · 2023P000985 · K23MH131793

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗